Surge in Rare Pediatric Brain Disorder Linked to Flu Season - News Center
A surge of influenza-associated acute necrotizing encephalopathy occurred among children during the 2024–2025 U.S. flu season, mainly affecting previously healthy children under age eight.
Moderna says mRNA flu vaccine sailed through trial, beating standard shot
Moderna's new mRNA-based flu vaccine, mRNA-1010, demonstrated a 27 percent higher efficacy rate in preventing influenza infections compared to the standard flu shot in a trial with nearly 41,000 participants aged 50 and older.